Researchers at the University of Toronto have revealed the binding action of the bacterial toxin responsible for toxic shock syndrome. Although similar to the toxin that causes diarrhea, the two proteins behave differently due to a short amino acid sequence, which the researchers were able to manipulate.
Browsing: Disease Area > Bacterial
Rebiotix (MN, USA) recently announced positive preliminary results from an ongoing clinical trial investigating the use of an investigational microbiota-based formulation, RBX2660, for the reduction of C. diff infection.
Researchers from Princeton University have uncovered an antibiotic molecule capable of killing both Gram-negative and Gram-positive bacteria using two simultaneous mechanisms, while also avoiding antibiotic resistance.
Emerging evidence has suggested that B cells and humoral immunity could modulate the immune response to intracellular pathogens. We speak to Babak Javid about his research on this topic and the importance of learning about immune factors in order to develop vaccination strategies and to understand latent TB.
Novel research suggests that some drugs may prevent the acquisition of resistance genes by preventing the induction of bacterial ‘competence’.
Catch up on February’s industry headlines, including an MRSA breakthrough, a patent lawsuit, and the latest updates on the coronavirus outbreak and its impact on the biotechnology industry worldwide.
The development of a paper-based, point-of-care diagnostic test may enable clinicians to rapidly detect bacterial infections and their antibiotic susceptibility with a simple colorimetric readout.
Using machine-learning, researchers have discovered a new antibiotic that is able to kill bacteria resistant to other antibiotics.
Dressings are long-established in the medical field for keeping wounds clean and preventing secondary infections. Here, Tim Sandle discusses technological advances with dressings for wound treatment and detection, including the incorporation of antimicrobials
This opinion piece looks at the impact a precision (or personalized) medicine approach could have in sepsis, including early and accurate microbiologic diagnosis, determining the host immune response signature and assessing individual response to treatment.